Literature DB >> 12398086

How do we optimize outcomes for patients with severe community-acquired pneumonia?

Michael S Niederman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12398086     DOI： 10.1007/s00134-002-1324-4

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  12 in total

1.  Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America.

Authors:  J G Bartlett; S F Dowell; L A Mandell; T M File; D M Musher; M J Fine
Journal:  Clin Infect Dis       Date:  2000-09-07       Impact factor: 9.079

2.  Associations between empirical antimicrobial therapy at the hospital and mortality in patients with severe community-acquired pneumonia.

Authors:  J Rello; M Catalán; E Díaz; M Bodí; B Alvarez
Journal:  Intensive Care Med       Date:  2002-04-25       Impact factor: 17.440

3.  Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group.

Authors:  J D Heffelfinger; S F Dowell; J H Jorgensen; K P Klugman; L R Mabry; D M Musher; J F Plouffe; A Rakowsky; A Schuchat; C G Whitney
Journal:  Arch Intern Med       Date:  2000-05-22

4.  Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia.

Authors:  P P Gleason; T P Meehan; J M Fine; D H Galusha; M J Fine
Journal:  Arch Intern Med       Date:  1999-11-22

5.  Failure of intensive care unit support to influence mortality from pneumococcal bacteremia.

Authors:  E W Hook; C A Horton; D R Schaberg
Journal:  JAMA       Date:  1983-02-25       Impact factor: 56.272

6.  Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity.

Authors:  M Ruiz; S Ewig; M A Marcos; J A Martinez; F Arancibia; J Mensa; A Torres
Journal:  Am J Respir Crit Care Med       Date:  1999-08       Impact factor: 21.405

7.  Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia.

Authors:  G W Waterer; G W Somes; R G Wunderink
Journal:  Arch Intern Med       Date:  2001 Aug 13-27

8.  Adherence to ATS guidelines for hospitalized patients with community-acquired pneumonia.

Authors:  D C Malone; H M Shaban
Journal:  Ann Pharmacother       Date:  2001-10       Impact factor: 3.154

9.  Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group.

Authors:  M P Fink; D R Snydman; M S Niederman; K V Leeper; R H Johnson; S O Heard; R G Wunderink; J W Caldwell; J J Schentag; G A Siami
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

10.  A five-year study of severe community-acquired pneumonia with emphasis on prognosis in patients admitted to an intensive care unit.

Authors:  O Leroy; C Santré; C Beuscart; H Georges; B Guery; J M Jacquier; G Beaucaire
Journal:  Intensive Care Med       Date:  1995-01       Impact factor: 17.440
View more
  2 in total

1.  Clinical and economic burden of community-acquired pneumonia in the Veterans Health Administration, 2011: a retrospective cohort study.

Authors:  John M McLaughlin; Maribeth H Johnson; Stephen A Kagan; Stephanie L Baer
Journal:  Infection       Date:  2015-05-17       Impact factor: 3.553

2.  Time to intubation is associated with outcome in patients with community-acquired pneumonia.

Authors:  Sami Hraiech; Julie Alingrin; Stéphanie Dizier; Julie Brunet; Jean-Marie Forel; Bernard La Scola; Antoine Roch; Laurent Papazian; Vanessa Pauly
Journal:  PLoS One       Date:  2013-09-19       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.